Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00323284 · ClinicalTrials.gov registry record · Phase 3
A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma
A Phase 3 study, sponsored by Glaukos Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
NCT00323284 is a Phase 3 study that has completed, run by Glaukos Corporation. The registered enrollment target is 240 participants.
The verdict
NCT00323284, a Phase 3 study, has completed, sponsored by Glaukos Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with open-angle glaucoma or ocular hypertension and co-existing cataract.
Interventions
- DEVICE iStent plus Cataract Surgery
- PROCEDURE Cataract surgery only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2005-06 |
| Est. Completion | 2010-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00323284
The ClinicalTrials.gov registry entry for NCT00323284 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Glaukos Corporation, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iStent plus Cataract Surgery is the first listed.
NCT00323284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00323284 about?
NCT00323284 is a clinical study titled "A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma". The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with open-angle glaucoma or ocular hypertension and co-existing cataract.
What is the current status of trial NCT00323284?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2005-06. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00323284?
The interventions under investigation include: iStent plus Cataract Surgery (DEVICE), Cataract surgery only (PROCEDURE).
Who is sponsoring clinical trial NCT00323284?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.